We are live on ! Find out more
CRVO icon

CervoMed

14 hedge funds and large institutions have $2.32M invested in CervoMed in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

200% more capital invested

Capital invested by funds: $774K → $2.32M (+$1.55M)

56% more funds holding

Funds holding: 914 (+5)

0.24% more ownership

Funds ownership: 0.08%0.32% (+0.24%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q2 2019 in Review

14 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2019, worth a combined $2.32M — up 200% from $774K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CRVO positions and 2 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.68M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $78K sold.

  • 14 institutional investors held CervoMed (CRVO) as of Q2 2019, up from 9 in Q1 2019.
  • Funds reported $2.32M of CervoMed stock for Q2 2019, up 200% quarter-over-quarter.
  • 7 funds opened new CervoMed positions in Q2 2019 and 2 closed out, a net change of +5 holders.
  • The largest CervoMed buyer in Q2 2019 was Sabby Management, an estimated $1.68M added.
  • The largest CervoMed seller in Q2 2019 was Bridgeway Capital Management, an estimated $78K sold.

Based on aggregated 13F filings for Q2 2019.